tiprankstipranks
Pharmaxis Ltd (AU:SNT)
ASX:SNT
Australian Market

Pharmaxis Ltd (SNT) Income Statement

Compare
10 Followers

Pharmaxis Ltd Income Statement

Last quarter (Q4 2022), Pharmaxis Ltd's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Pharmaxis Ltd's net income was $―. See Pharmaxis Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 7.43M$ 6.68M$ 7.03M$ 5.68M$ 7.28M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 3.24M$ 3.15M$ 3.24M$ 2.62M$ 3.35M
EBITDA
$ -12.15M$ 551.00K$ -18.23M$ -17.20M$ 10.33M
Operating Income
$ -22.77M$ -20.64M$ -21.47M$ -25.88M$ -26.35M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -1.94M$ -2.97M$ -13.94M$ -20.06M$ 6.43M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Pharmaxis Ltd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis